IKZF1 and acute lymphoblastic leukemia: In the Ph/+/ B-ALL subgroup, although the median EFS and OS were higher in the IKZF1 non-deleted group—8 vs. 2 months and 15 versus 2 months, respectively—these differences were not statistically significant (p = 0.849, and p = 0.649, respectively).